Screener
Nurix Therapeutics, Inc. NRIX Collaboration revenue — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026.
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
| Line item | Three Months Ended May 31, 2026 | Three Months Ended May 31, 2025 | Six Months Ended May 31, 2026 | Six Months Ended May 31, 2025 |
|---|---|---|---|---|
| Revenue: | ||||
| Collaboration revenue | $9,043 | $14,056 | $15,295 | $32,509 |
| License revenue | — | 30,000 | — | 30,000 |
| Total revenue | 9,043 | 44,056 | 15,295 | 62,509 |
| Operating expenses: | ||||
| Research and development | 87,653 | 78,096 | 171,789 | 147,759 |
| General and administrative | 15,594 | 14,282 | 30,205 | 25,936 |
| Total operating expenses | 103,247 | 92,378 | 201,994 | 173,695 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Nurix Therapeutics, Inc.'s collaboration revenue — revenue?
- Nurix Therapeutics, Inc. (NRIX) reported collaboration revenue — revenue of $9.04M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s collaboration revenue — revenue changed year-over-year?
- Nurix Therapeutics, Inc.'s collaboration revenue — revenue decreased by 35.7% year-over-year, from $14.06M to $9.04M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s collaboration revenue — revenue?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s collaboration revenue — revenue has grown at a 11.8% compound annual growth rate (CAGR), from $38.63M to $53.98M.
- What does collaboration revenue — revenue mean?
- This metric represents the revenue recognized from strategic partnerships, research collaborations, and licensing agreements with other biopharmaceutical entities. It reflects the company's ability to monetize its proprietary drug discovery platforms and pipeline assets through milestone payments, upfront fees, and cost-sharing arrangements. This revenue stream is a critical indicator of the company's external validation and its capacity to fund internal R&D efforts through non-dilutive capital.
Ask your AI about Nurix Therapeutics, Inc.'s collaboration revenue — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude